Ingredients Categories

News

Enfamil launches infant formula containing A2 milk proteins

14 Sep 2020

Infant formula brand Enfamil launched a new, FDA-regulated line containing only A2 milk proteins and the omega-3 protein DHA, a key building block in brain and eye development. The A2-only dairy is sourced directly from European cows that naturally produce milk without the A1 protein that is known to cause digestive discomfort.

Focusing on A2 protein is an innovative approach to milk that has been a bright spot in an otherwise limp industry, and Enfamil is grasping onto this trend for its infant formulas.

Enfamil launches infant formula containing A2 milk proteins

This growth in A2 milk stands in stark contrast to the overall U.S. dairy industry which has been in steep decline for the last several years. Things have become so strained that major dairy companies like Dean Foods and Borden Dairy filed for bankruptcy in the last year. However, other companies like New Zealand-based A2 Milk Company reported a 91% jump in revenue in the United States over its last fiscal year. Globally, the company reported a 33% increase to $1.1 billion from 2019.

Innovation in the milk segment is an attractive proposition to consumers. Coca-Cola’s Fairlife brand, an ultra-filtered, high-protein and lactose-free milk is also seeing expanding demand despite a dairy industry that has been battered by the pandemic. These trends toward re-interpreted versions of classic dairy milk demonstrate that consumers are still interested in the animal-based product.

Enfamil not only taps into this trend toward innovative dairy but works to explain why A2 milk is so different from what most consumers are familiar with. The company said that A2 milk is similar to breast milk, claiming that the A1 protein was a mutation and that cows “historically only produced the A2 protein.” This claim is supported by the California Dairy Research Foundation which said a genetic mutation 8,000 years ago occurred in the Holstein cow breed and resulted in the production of the A1 beta-casein protein. This mutation in the beta-casein gene led to 12 genetic variants and spread across multiple breeds. Today, the A1 protein is common in cattle in the Western world.

However, Enfamil is taking things a step further than just offering A2 protein to consumers. Not only is the infant nutrition company touting the formula’s use of A2 protein, but it is promoting it as a safe alternative to European formula imports. According to the release, “Enfamil Premium A2 gives parents both the confidence of FDA regulated formula and the benefits of European A2 cow milk proteins, along with an expert recommended amount of DHA. With this new formula from Enfamil, it’s a safe alternative to imported European formulas and does not have added table sugar, corn, artificial growth hormones, antibiotics, or GMOs.” The World Health Organization recommends a total amount of DHA that ranges from between 0.2% to 0.36% of an infant’s total fatty acid intake. Enfamil’s A2 formula has a total DHA content of 0.32%.

Related news

The new geopolitics of food: How to create a resilient, self-reliant industry

The new geopolitics of food: How to create a resilient, self-reliant industry

2 Jul 2026

Today's global food system is fragile and volatile and governments must respond by building “resilient self-reliance”, says the think tank, IPES-Food.

Read more 
Arla Foods and DMK Group merge in big-dairy development

Arla Foods and DMK Group merge in big-dairy development

24 Jun 2026

International dairy company Arla Foods and German farmer-owned business DMK Group are to merge, creating one of Europe’s biggest dairy cooperatives.

Read more 
Mycotoxin warning for processed plant-based foods

Mycotoxin warning for processed plant-based foods

18 Jun 2026

Almost all plant-based food and drinks contain mycotoxins – naturally-occurring toxic compounds produced by fungi – and raw material monitoring should be extended, say researchers.

Read more 
Market watch: Allergen-free no longer a 'fringe niche'

Market watch: Allergen-free no longer a 'fringe niche'

17 Jun 2026

Allergen-free food and drink products are now “structurally embedded” into the wider health and wellness category, with significant innovation happening at retail and brand level, say experts.

Read more 
IFF prepares to sell food ingredients business to CVC

IFF prepares to sell food ingredients business to CVC

16 Jun 2026

With IFF set to sell its food ingredients division to CVC Capital Partners for €3.7 billion, we look at how mergers, acquisitions, and divestments are shaping the sector.

Read more 
US industry panel recommends new UPF policy definition

US industry panel recommends new UPF policy definition

11 Jun 2026

US-based Healthy Eating Research has proposed an ingredient-based approach to defining ultra-processed foods (UPFs) to make them easier to identify for policy purposes.

Read more 
GLP-1 food and drink innovation: ‘Flavour still matters’

GLP-1 food and drink innovation: ‘Flavour still matters’

10 Jun 2026

Many GLP-1 users have altered flavour preferences, becoming highly nuanced and “complex”, with important implications for how brands formulate, says the Institute of Grocery Distribution.

Read more 
Ingredion’s Tate & Lyle takeover bid offers scale and science

Ingredion’s Tate & Lyle takeover bid offers scale and science

5 Jun 2026

US ingredients business Ingredion has made a £2.7bn takeover bid for its London-listed peer Tate & Lyle.

Read more 
Food and drink giants call for postponements to EU packaging laws

Food and drink giants call for postponements to EU packaging laws

1 Jun 2026

Some of Europe’s biggest companies, including Coca-Cola, Kraft Heinz, McCormick, and Mondelēz, have called for new EU rules on packaging to be delayed.

Read more 
What will US front-of-pack nutrition labels look like?

What will US front-of-pack nutrition labels look like?

28 May 2026

US front of pack nutrition labels are on the way – but policymakers and researchers are divided on how best to design them.

Read more